Ulcerative colitis trials in Mexico
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Enrolling by invitationLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Celaya, Saltillo, Tlajomulco de Zúñiga
- Age
- 18 years and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - Phase 3Taking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mérida, Mexico City, Monterrey, Morelia, Puebla City, Tlalnepantla, Veracruz
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - Phase 2Taking peopleLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Where
- Chihuahua City, Durango, Guadajalara, Guadalajara, Mexico City, San Pedro Garza García, Tijuana, Tlalnepantla, Tlalpan, Veracruz
- Age
- 18 years to 80 years
- People
- 252 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07186101 - Phase 2Taking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Chihuahua City, Ciudad de Tijuana, Guadalajara, Irapuato, Mexico City, Monterrey, Querétaro
- Age
- 18 years to 80 years
- People
- 1,431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - Phase 3Taking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Guadalajara, Léon, San Luis Potosí City, San Pedro Garza García
- Age
- 18 years and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - Phase 2Taking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Guadalajara, Mérida, San Luis Potosí City, Tlajomulco de Zúñiga, Veracruz
- Age
- 18 years and over
- People
- 224 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00 - Phase 2Taking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Celaya, Coyoacán, Querétaro, Saltillo, Tlajomulco de Zúñiga
- Age
- 18 years to 75 years
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00